Jason O’Byrne
CFO
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Vir Biotechnology, Inc. (VIR) | Executive Vice President and Chief Financial Officer | $534,417 | $1,951,828 |
| 2024 | Vir Biotechnology, Inc. (VIR) | Executive Vice President and Chief Financial Officer | $130,492 | $1,919,827 |
| 2021 | Caribou Biosciences, Inc. (CRBU) | M.B.A. Chief financial officer | $358,580 | $3,449,030 |
| 2020 | Caribou Biosciences, Inc. (CRBU) | M.B.A. Chief financial officer | — | — |
Executive changes
Earnings-call appearances
-
Vir Biotechnology, Inc. Q1 FY2026 Earnings Call2026-05-06
Vir Biotechnology, Inc. (VIR)
-
Vir Biotechnology, Inc. Q4 FY2025 Earnings Call2026-02-23
Vir Biotechnology, Inc. (VIR)
-
Vir Biotechnology, Inc. Q3 FY2025 Earnings Call2025-11-05
Vir Biotechnology, Inc. (VIR)
-
Vir Biotechnology, Inc. Q2 FY2025 Earnings Call2025-08-06
Vir Biotechnology, Inc. (VIR)
-
Vir Biotechnology, Inc. Q4 FY2024 Earnings Call2025-02-26
Vir Biotechnology, Inc. (VIR)
-
Vir Biotechnology, Inc. Q3 FY2024 Earnings Call2024-10-31
Vir Biotechnology, Inc. (VIR)